Entrinsic Bioscience, LLC (EBS), a pioneering life science company, announced that the European Patent Office (EPO) upheld the claims in EBS’ licensed European patent (EP2968241), which was the subject of an Opposition mounted by an undisclosed Opponent. EP2968241 is part of a substantial intellectual property portfolio that EBS licenses from the University of Florida Research Foundation, Inc.
February 22, 2022
· 2 min read